Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Consistency of Fendrix (HBV-MPL) Vaccine vs Engerix-B in Healthy Volunteers
NCT00697866Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2000
- Primary completion
- Feb 2001
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 3, randomised, single-blind trial of hepatitis b vaccine recombinant in hepatitis B (HBV) (4 arms), sponsored by GSK. Primary endpoint: Anti-HBs antibody concentrations at Month 3. Started Aug 2000; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00697866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697866.